BR9909668A - Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções - Google Patents

Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções

Info

Publication number
BR9909668A
BR9909668A BR9909668-4A BR9909668A BR9909668A BR 9909668 A BR9909668 A BR 9909668A BR 9909668 A BR9909668 A BR 9909668A BR 9909668 A BR9909668 A BR 9909668A
Authority
BR
Brazil
Prior art keywords
infections
therapeutic
prophylactic treatment
organophosphorus compounds
organophosphorus
Prior art date
Application number
BR9909668-4A
Other languages
English (en)
Inventor
Jomaa Hassan
Original Assignee
Jomaa Hassan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19825585A external-priority patent/DE19825585A1/de
Priority claimed from DE19843222A external-priority patent/DE19843222A1/de
Priority claimed from DE19843223A external-priority patent/DE19843223A1/de
Application filed by Jomaa Hassan filed Critical Jomaa Hassan
Publication of BR9909668A publication Critical patent/BR9909668A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Patente de Invenção: <B>"USO DE COMPOSTOS DE ORGANOFóSFORO PARA O TRATAMENTO TERAPêUTICO E PROFILáTICO DE INFECçõES"<D>. Esta invenção refere-se ao uso de compostos de organofósforo de Fórmula geral (I): para o tratamento terapêutico e profilático de infecções em humanos e animais causadas por vírus, fungos e parasitas.
BR9909668-4A 1998-04-14 1999-04-13 Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções BR9909668A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19816196 1998-04-14
DE19825585A DE19825585A1 (de) 1998-04-14 1998-06-09 Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
DE19843222A DE19843222A1 (de) 1998-09-22 1998-09-22 Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE19843223A DE19843223A1 (de) 1998-09-22 1998-09-22 Phosphororganische Verbindungen und ihre Verwendung
PCT/EP1999/002462 WO1999052515A2 (de) 1998-04-14 1999-04-13 Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen

Publications (1)

Publication Number Publication Date
BR9909668A true BR9909668A (pt) 2000-12-19

Family

ID=27438787

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909668-4A BR9909668A (pt) 1998-04-14 1999-04-13 Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções

Country Status (16)

Country Link
US (3) US6680308B1 (pt)
EP (1) EP1071409B1 (pt)
JP (1) JP3657516B2 (pt)
CN (1) CN1297352A (pt)
AP (1) AP2000001942A0 (pt)
AT (1) ATE251903T1 (pt)
AU (1) AU747407B2 (pt)
BR (1) BR9909668A (pt)
CA (1) CA2328159C (pt)
HU (1) HUP0101716A3 (pt)
MX (1) MXPA00010068A (pt)
OA (1) OA11538A (pt)
PL (1) PL344535A1 (pt)
SK (1) SK15222000A3 (pt)
TR (1) TR200002965T2 (pt)
WO (1) WO1999052515A2 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843222A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
DE19854403A1 (de) * 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
DE19859426A1 (de) * 1998-12-22 2000-07-06 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
JP2004508283A (ja) * 2000-02-18 2004-03-18 ヨマー、ファルマカ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 有機リン化合物およびその使用
DE10127936A1 (de) * 2000-06-08 2001-12-13 Jomaa Pharmaka Gmbh Phosphororganische Hydroxamsäurederivate als Herbizide
WO2001093872A1 (de) * 2000-06-08 2001-12-13 Jomaa Pharmaka Gmbh Verwendung von phosphororganischen hydroxamsäurederivaten zur herstellung von arzneimitteln
WO2002078714A1 (de) * 2001-03-30 2002-10-10 Jomaa Pharmaka Gmbh Magensaftresistente formulierungen zur applikation von antiinfektiös wirkenden verbindungen, die den 2-c-methylerythrose-4-stoffwechselweg hemmen, sowie ihren salzen und estern
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
DE10237085A1 (de) * 2002-08-09 2004-02-19 Bioagency Ag Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen
DE10337761A1 (de) * 2003-08-14 2005-03-17 Bioagency Ag Phosphororganische 4-Iminohydantoinderivate
DE10356410A1 (de) * 2003-11-24 2005-06-23 Bioagency Ag Phosphororganische Verbindungen und deren Verwendung
AU2004296784B2 (en) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
JP2007532571A (ja) * 2004-04-07 2007-11-15 インターベツト・インターナシヨナル・ベー・ベー ベンズイミダゾール、アベルメクチンおよびプラジカンテルの有効組成物および関連する使用方法
DE102005033210B4 (de) * 2005-06-22 2008-04-30 Heraeus Kulzer Gmbh Polymethylmethacrylat-Knochenzement
DE102005032110B3 (de) * 2005-07-07 2006-08-17 Heraeus Kulzer Gmbh Gefärbter Polymethylmethacrylat-Knochenzement und Verfahren zu seiner Herstellung
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
KR100795515B1 (ko) * 2007-01-11 2008-01-16 바이오스펙트럼 주식회사 아테미시닌을 포함하는 피부 미백용 조성물
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
CA2697373C (en) 2007-08-27 2019-05-21 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
WO2009085355A2 (en) 2007-10-01 2009-07-09 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
WO2009128964A2 (en) * 2008-01-23 2009-10-22 The Regents Of The University Of California Ensemble-based virtual screening reveals novel antiviral compounds for avian influenza neuraminidase
FI20080665A0 (fi) * 2008-12-18 2008-12-18 Glykos Finland Oy Luonnollisen tyyppiset sakkaridikoostumukset
EP2404601A1 (en) 2010-07-06 2012-01-11 BioAgency AG New drug combinations for the treatment of Malaria
CA2863083C (en) 2012-01-26 2023-09-19 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2014008248A2 (en) * 2012-07-03 2014-01-09 Graceland Biotechnology Inc. Compositions and methods for treating and inhibiting viral infections
US11446241B2 (en) 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
EP3030084A4 (en) * 2013-07-29 2016-07-27 Attillaps Holdings Organophosphates for the treatment of skin disorders
CN103948692B (zh) * 2014-05-14 2016-09-07 广西南宁市桃源兽药厂 一种含有赤芍和阿米卡星的畜禽用复方药物
DK3010511T3 (en) 2014-09-12 2018-03-05 Antibiotx As ANTIBACTERIAL USE OF HALOGENERED SALICYLANILIDES
CN104606215B (zh) * 2014-12-31 2017-10-10 中国医学科学院病原生物学研究所 一种抑制肠道病毒71的药物
EP3294448A4 (en) 2015-05-14 2018-12-12 Longhorn Vaccines and Diagnostics, LLC Rapid methods for the extraction of nucleic acids from biological samples
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN111419841B (zh) * 2020-03-25 2021-05-14 山东省肿瘤防治研究院（山东省肿瘤医院） 一种抗白色念珠菌组合药物
EP3960176A1 (en) 2020-08-26 2022-03-02 DMG Deutsche Malaria GmbH Piperaquine and related drug combinations for use in the treatment of covid-19

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887353A (en) * 1971-06-25 1975-06-03 Gates Rubber Co Diethyl betaaminoethylphosphonate as an algaecide
JPS51125750A (en) * 1974-09-17 1976-11-02 Rikagaku Kenkyusho Agermicide for agricuture and gardening
GB1580899A (en) 1976-07-27 1980-12-10 Fujisawa Pharmaceutical Co Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
US4206156A (en) 1976-07-27 1980-06-03 Fujisawa Pharmaceutical Company, Limited Hydroxyaminohydrocarbonphosphonic acids
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4330529A (en) * 1978-02-15 1982-05-18 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
JPS5746917A (en) * 1980-09-03 1982-03-17 Fujisawa Pharmaceut Co Ltd Antibacterial agent
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US4693642A (en) * 1986-07-02 1987-09-15 General Motors Corporation Line boring apparatus
US4846872A (en) * 1986-08-11 1989-07-11 Fujisawa Pharmaceutical Co., Ltd. Herbicide
US5091375A (en) * 1988-02-29 1992-02-25 Bayer Ag Nikkomycin derivatives
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ATE250919T1 (de) * 1996-08-02 2003-10-15 Plum Kemi Produktion As Oel-im-wasser emulsion zur gruendlichen reinigung,zum schutz oder verbesserung der haut
DE19854403A1 (de) * 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung

Also Published As

Publication number Publication date
US20110306578A1 (en) 2011-12-15
CN1297352A (zh) 2001-05-30
AU4120899A (en) 1999-11-01
EP1071409A2 (de) 2001-01-31
WO1999052515A3 (de) 2000-01-20
HUP0101716A3 (en) 2003-01-28
AU747407B2 (en) 2002-05-16
US6680308B1 (en) 2004-01-20
MXPA00010068A (es) 2002-08-06
EP1071409B1 (de) 2003-10-15
SK15222000A3 (sk) 2001-03-12
CA2328159A1 (en) 1999-10-21
HUP0101716A1 (hu) 2002-01-28
JP3657516B2 (ja) 2005-06-08
TR200002965T2 (tr) 2001-05-21
CA2328159C (en) 2011-06-14
US20040082549A1 (en) 2004-04-29
ATE251903T1 (de) 2003-11-15
JP2002511406A (ja) 2002-04-16
WO1999052515A2 (de) 1999-10-21
PL344535A1 (en) 2001-11-05
OA11538A (en) 2004-05-24
AP2000001942A0 (en) 2000-12-31

Similar Documents

Publication Publication Date Title
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
BR9909730A (pt) Dihidropirimidinas
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
BR0014293A (pt) Uso de retigabina para o tratamento de dor neuropática
BR0211251B1 (pt) composição para o tratamento de cabelo e/ou couro cabeludo.
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
BR9914390B1 (pt) benzoil-ciclohexano-dionas, agentes herbicidas apresentando as mesmas, processo para o combate de plantas indesejadas e aplicação dos referidos compostos.
BR0206266A (pt) Heterocìclicos de difenila substituìda útil para tratar infecção por hcv
BRPI0411900A (pt) compostos antivirais e métodos
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
BR0309095A (pt) Uso de osteoprotegerina para o tratamento e/ou prevenção de doença fibrótica
BR9812837A (pt) Processo para fazer um composto, e, composto
EP1262177A3 (en) Medical use of thyromimetic compounds to treat hair loss and compositions
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
PT1299395E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus
BR0012291A (pt) Fenoxifluorpirimidinas
PT1140113E (pt) Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos
BR9807227B1 (pt) composiÇço herbicida para tratamento foliar, processo de eliminaÇço e uso de referida composiÇço herbicida.
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
BR9913990A (pt) Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas
ATE281173T1 (de) Behandlung einer virusinfektion bei schweinen
BR9808028A (pt) Composição biocida e uso da mesma.
BR0015996A (pt) Compostos de triazinona para o tratamento de doenças causadas pela infestação de protozoários parasìticos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.